(19)
(11) EP 4 476 547 A1

(12)

(43) Date of publication:
18.12.2024 Bulletin 2024/51

(21) Application number: 23715752.4

(22) Date of filing: 06.02.2023
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/6893; G01N 2800/323; G01N 2800/324
(86) International application number:
PCT/EP2023/025053
(87) International publication number:
WO 2023/147946 (10.08.2023 Gazette 2023/32)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 07.02.2022 GB 202201531

(71) Applicant: Randox Laboratories Ltd
Crumlin, Antrim BT29 4QY (GB)

(72) Inventors:
  • INNOCENZI, Paul John
    Crumlin BT29 4QY (GB)
  • FITZGERALD, Peter
    Crumlin BT29 4QY (GB)
  • MCCONNELL, Ivan
    Crumlin BT29 4QY (GB)

   


(54) BIOMARKERS OF CARDIOVASCULAR DISEASE